David Vereide
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
-
- Cancer-related molecular mechanisms research
Papers in
-
- Pluripotent Stem Cells Research 5
- Single-cell and spatial transcriptomics 2
- Congenital heart defects research 2
- CRISPR and Genetic Engineering 2
- Oncology 5
- Viral-associated cancers and disorders 5
- Co-authors
- Bill Sugden (5 shared papers)James A. Thomson (7 shared papers)Li‐Fang Chu (3 shared papers)Brian E. McIntosh (3 shared papers)Ron Stewart (3 shared papers)Zhonggang Hou (1 shared paper)Jeea Choi (1 shared paper)Ning Leng (1 shared paper)
- Journals
- Stem Cell Reports (3 papers)Journal of Virology (1 paper)Cell Reports Medicine (1 paper)Genome biology (1 paper)Advances in cancer research (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
David Vereide
12 papers receiving 930 citations
Peers
Comparison fields: 5 of 66
- Oncology 309
- Cancer Research 144
- Molecular Biology 582
- Biophysics 46
- Pathology and Forensic Medicine 130
Countries citing papers authored by David Vereide
This map shows the geographic impact of David Vereide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vereide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vereide more than expected).
Fields of papers citing papers by David Vereide
This network shows the impact of papers produced by David Vereide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vereide. The network helps show where David Vereide may publish in the future.
Co-authors
The 25 scholars most cited alongside David Vereide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 302 | |
| 2 | 2015 | 159 | |
| 3 | 2013 | 140 | |
| 4 | 2011 | 118 | |
| 5 | 2010 | 71 | |
| 6 | 2009 | 54 | |
| 7 | 2009 | 31 | |
| 8 | 2010 | 25 | |
| 9 | 2014 | 21 | |
| 10 | 2018 | 8 | |
| 11 | 2018 | 6 | |
| 12 | 2025 | 1 |
About David Vereide
David Vereide is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Rheumatology and Surgery, having authored 12 papers that have together received 936 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (5 papers), Pluripotent Stem Cells Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Single-cell and spatial transcriptomics (2 papers), Congenital heart defects research (2 papers), CRISPR and Genetic Engineering (2 papers) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Oncology (309 citations), Cancer Research (144 citations), Molecular Biology (582 citations), Biophysics (46 citations) and Pathology and Forensic Medicine (130 citations). David Vereide has collaborated with scholars based in United States and Germany. Frequent co-authors include Bill Sugden, James A. Thomson, Li‐Fang Chu, Brian E. McIntosh, Ron Stewart, Zhonggang Hou, Jeea Choi, Ning Leng, Daniel Mamott and Christina Kendziorski. Their work appears in journals such as Stem Cell Reports, Journal of Virology, Cell Reports Medicine, Genome biology and Advances in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.